A widely prescribed steroid used to control brain swelling in cancer patients may be undermining their treatment, according to new research.
Scientists found that dexamethasone, routinely administered to people with brain tumors, significantly suppresses immune function, potentially rendering immunotherapy treatments ineffective.
